nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—Papaverine—PDE4B—hematologic cancer	0.0317	0.349	CrCbGaD
Bevantolol—Verapamil—ABCC3—hematologic cancer	0.0155	0.17	CrCbGaD
Bevantolol—Verapamil—SLC22A1—hematologic cancer	0.0108	0.118	CrCbGaD
Bevantolol—Carvedilol—VEGFA—hematologic cancer	0.0106	0.116	CrCbGaD
Bevantolol—Verapamil—ABCG2—hematologic cancer	0.00751	0.0825	CrCbGaD
Bevantolol—Metoprolol—ABCB1—hematologic cancer	0.00408	0.0449	CrCbGaD
Bevantolol—Verapamil—ABCB1—hematologic cancer	0.00313	0.0343	CrCbGaD
Bevantolol—Propafenone—ABCB1—hematologic cancer	0.00301	0.0331	CrCbGaD
Bevantolol—Carvedilol—ABCB1—hematologic cancer	0.00271	0.0298	CrCbGaD
Bevantolol—Propranolol—ABCB1—hematologic cancer	0.00206	0.0227	CrCbGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000247	0.000271	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	0.000245	0.00027	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000243	0.000267	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CBL—hematologic cancer	0.000242	0.000266	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	0.000242	0.000266	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000241	0.000266	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	0.00024	0.000264	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL3—hematologic cancer	0.00024	0.000264	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	0.000237	0.000261	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	0.000237	0.000261	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000237	0.00026	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	0.000236	0.00026	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTPN1—hematologic cancer	0.000235	0.000259	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	0.000234	0.000257	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	0.000233	0.000256	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PTPN11—hematologic cancer	0.000232	0.000256	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	0.000232	0.000255	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RASGRP1—hematologic cancer	0.000232	0.000255	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000231	0.000254	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SYK—hematologic cancer	0.000231	0.000254	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	0.000231	0.000254	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	0.00023	0.000253	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	0.00023	0.000253	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000229	0.000252	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	0.000229	0.000252	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	0.000228	0.00025	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	0.000227	0.000249	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	0.000227	0.000249	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	0.000226	0.000249	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	0.000225	0.000248	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	0.000225	0.000248	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	0.000225	0.000248	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000224	0.000247	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	0.000223	0.000245	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	0.000223	0.000245	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	0.000222	0.000244	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	0.000222	0.000244	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	0.000222	0.000244	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	0.000222	0.000244	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	0.000221	0.000244	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	0.00022	0.000242	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	0.00022	0.000242	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	0.000219	0.000241	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	0.000218	0.00024	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	0.000217	0.000239	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	0.000217	0.000239	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000216	0.000238	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	0.00021	0.000231	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000209	0.00023	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	0.000208	0.000229	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	0.000208	0.000229	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	0.000208	0.000229	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	0.000207	0.000228	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	0.000206	0.000226	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	0.000205	0.000226	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	0.000205	0.000225	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	0.000203	0.000223	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	0.000201	0.000221	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	0.000201	0.000221	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	0.0002	0.00022	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	0.0002	0.00022	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.0002	0.00022	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000198	0.000218	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000196	0.000216	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	0.000196	0.000215	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	0.000196	0.000215	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CD86—hematologic cancer	0.000192	0.000211	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	0.000191	0.000211	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	0.000191	0.00021	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HES1—hematologic cancer	0.000189	0.000208	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	0.000188	0.000207	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	0.000188	0.000207	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	0.000186	0.000205	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	0.000186	0.000205	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	0.000186	0.000205	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	0.000184	0.000203	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	0.000183	0.000202	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	0.000183	0.000202	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	0.000183	0.000201	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	0.000183	0.000201	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	0.000182	0.0002	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	0.000181	0.000199	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	0.000181	0.000199	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	0.00018	0.000198	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	0.00018	0.000198	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	0.00018	0.000198	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	0.000179	0.000197	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	0.000178	0.000196	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	0.000178	0.000196	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	0.000177	0.000194	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	0.000177	0.000194	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	0.000175	0.000192	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	0.000175	0.000192	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	0.000173	0.00019	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	0.000173	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	0.000173	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	0.000173	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	0.000173	0.00019	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	0.00017	0.000187	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	0.000169	0.000186	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	0.000169	0.000186	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	0.000169	0.000186	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	0.000169	0.000186	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	0.000168	0.000185	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	0.000167	0.000183	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	0.000166	0.000183	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TERT—hematologic cancer	0.000166	0.000183	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	0.000165	0.000182	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	0.000164	0.000181	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	0.000162	0.000179	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	0.000162	0.000178	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	0.000162	0.000178	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	0.000161	0.000177	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	0.000161	0.000177	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	0.00016	0.000176	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	0.00016	0.000176	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	0.000159	0.000175	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	0.000158	0.000174	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	0.000157	0.000173	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	0.000157	0.000173	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	0.000157	0.000172	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	0.000153	0.000168	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	0.000152	0.000167	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	0.000152	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	0.000151	0.000166	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.00015	0.000165	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	0.00015	0.000165	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	0.000149	0.000164	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	0.000149	0.000163	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	0.000148	0.000163	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000147	0.000162	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FN1—hematologic cancer	0.000146	0.000161	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	0.000145	0.00016	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	0.000145	0.00016	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BAD—hematologic cancer	0.000144	0.000159	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	0.000144	0.000159	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	0.000143	0.000158	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	0.000143	0.000157	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	0.000142	0.000156	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	0.00014	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CD80—hematologic cancer	0.00014	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KIT—hematologic cancer	0.00014	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	0.00014	0.000154	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	0.00014	0.000154	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	0.000139	0.000153	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	0.000137	0.000151	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000137	0.00015	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	0.000136	0.00015	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	0.000136	0.00015	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	0.000134	0.000147	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	0.000134	0.000147	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	0.000133	0.000146	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	0.000133	0.000146	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	0.000132	0.000146	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	0.000132	0.000146	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	0.000131	0.000145	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	0.00013	0.000143	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	0.00013	0.000143	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	0.00013	0.000143	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	0.000129	0.000142	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	0.000129	0.000142	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	0.000126	0.000139	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	0.000124	0.000137	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	0.000124	0.000136	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	0.000124	0.000136	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	0.000123	0.000135	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	0.000123	0.000135	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	0.000122	0.000134	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000122	0.000134	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	0.000122	0.000134	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	0.000122	0.000134	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	0.000121	0.000133	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	0.00012	0.000132	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	0.00012	0.000132	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	0.000119	0.000131	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	0.000119	0.000131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	0.000119	0.00013	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	0.000118	0.00013	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	0.000118	0.00013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	0.000118	0.000129	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	0.000116	0.000128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	0.000116	0.000128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	0.000116	0.000127	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	0.000115	0.000126	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	0.000114	0.000126	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	0.000113	0.000124	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	0.000112	0.000123	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	0.000112	0.000123	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	0.000112	0.000123	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	0.000112	0.000123	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	0.000111	0.000122	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	0.00011	0.000121	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	0.000109	0.00012	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	0.000109	0.00012	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	0.000109	0.00012	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	0.000107	0.000118	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	0.000107	0.000118	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	0.000107	0.000117	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	0.000106	0.000117	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	0.000104	0.000114	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	0.000103	0.000114	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	0.000102	0.000113	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	0.000102	0.000113	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	0.000102	0.000112	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	0.000101	0.000111	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	0.000101	0.000111	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	0.0001	0.00011	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	9.98e-05	0.00011	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	9.94e-05	0.000109	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	9.85e-05	0.000108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL2—hematologic cancer	9.84e-05	0.000108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	9.79e-05	0.000108	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	9.77e-05	0.000108	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	9.59e-05	0.000105	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JUN—hematologic cancer	9.57e-05	0.000105	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	9.56e-05	0.000105	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	9.51e-05	0.000105	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	9.48e-05	0.000104	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	9.3e-05	0.000102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	9.28e-05	0.000102	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	9.28e-05	0.000102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	9.26e-05	0.000102	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	9.05e-05	9.96e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	9.03e-05	9.93e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EP300—hematologic cancer	8.83e-05	9.71e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	8.78e-05	9.66e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	8.59e-05	9.45e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SRC—hematologic cancer	8.58e-05	9.44e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	8.36e-05	9.2e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	8.28e-05	9.11e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	8.26e-05	9.08e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	8.07e-05	8.88e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	7.91e-05	8.7e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	7.89e-05	8.68e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	7.81e-05	8.59e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MYC—hematologic cancer	7.69e-05	8.46e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	7.67e-05	8.44e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	7.64e-05	8.4e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	7.47e-05	8.21e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	7.3e-05	8.03e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	7.15e-05	7.86e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	7.11e-05	7.82e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	6.99e-05	7.69e-05	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	6.59e-05	7.25e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	6.53e-05	7.18e-05	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	6.45e-05	7.09e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TP53—hematologic cancer	6.32e-05	6.95e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	6.04e-05	6.65e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—hematologic cancer	5.78e-05	6.36e-05	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	5.33e-05	5.87e-05	CbGpPWpGaD
